Skip to main content
logo
Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.1605
+0.0071 (4.63%)
At close: Aug 28, 2026

Sangamo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
66141213965151,093
Market Cap Growth
-59.07%-33.59%120.88%-81.28%-52.90%-50.50%
Enterprise Value
58137201-1204614
Last Close Price
0.160.421.020.543.147.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-205.04205.04---
PS Ratio
1.923.573.680.554.629.87
PB Ratio
-3.51-9.909.351.161.752.91
P/TBV Ratio
--9.351.162.493.88

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.693.473.48-1.835.54

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.02-1.881.340.460.150.13
Net Debt / Equity Ratio
0.44-0.41-0.50-0.52-0.90-1.11
Net Debt / EBITDA Ratio
0.08-0.060.120.431.402.40
Net Debt / FCF Ratio
0.09-0.060.170.171.081.62
Asset Turnover
0.470.490.430.480.170.13
Quick Ratio
0.640.741.021.782.532.99
Current Ratio
0.700.841.131.982.693.12
Return on Equity (ROE)
--2891.84%-185.39%-136.47%-57.37%-40.86%
Return on Assets (ROA)
-94.37%-83.66%-46.00%-19.63%-19.59%-13.80%
Return on Capital Employed (ROCE)
-1615.00%-625.10%-176.00%-97.20%-44.60%-30.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-185.48%-86.98%-46.02%-267.59%-37.37%-16.32%
FCF Yield
-136.04%-68.85%-31.67%-255.31%-47.38%-23.48%
Buyback Yield / Dilution
-52.37%-38.92%-15.62%-13.02%-6.76%-7.53%